VEGFA and myopia: <h4>Purpose</h4>Evaluating the impact for different number of Anti-vascular endothelial growth Factor (VEGF) injections on macular neovascularization (MNV) secondary to pathological myopia, during a 2-year follow-up period, in relation to visual outcome.<h4>Methods</h4>This was a multicenter, retrospective study of patients with myopic MNV (mMNV) for 24 months.<h4>Results</h4>A total of 55 patients with mMNV, with a mean age of 65.7 ± 14.5 years, met the inclusion criteria.